This segment focuses on the development, manufacturing, and sales of automated systems and instruments for laboratory automation and clinical diagnostics. These instruments are designed to streamline sample preparation workflows and enhance the efficiency of genetic and protein analysis. The segment's R&D activities are geared towards creating innovative solutions for molecular testing, including nucleic acid extraction and analysis. Technologies employed include microfluidics, robotics, and advanced automation software. The instruments are used in various applications, including in vitro diagnostics, genetic testing, and veterinary biochemical analysis. Future opportunities include expanding the product line to address emerging needs in personalized medicine and point-of-care diagnostics. PSS collaborates with other companies to co-develop and manufacture instruments, such as the nCounter Prep Station.

This segment involves the manufacturing and sales of plastic consumables and reagent kits used in conjunction with PSS's automated systems and instruments. These consumables are essential for the proper functioning of the instruments and ensure accurate and reliable results. The segment's R&D efforts are focused on developing high-quality reagents and optimizing their performance with the company's instruments. Technologies used include chemical synthesis, formulation development, and quality control testing. The reagent kits and consumables are used in a wide range of applications, including genetic analysis, protein analysis, and in vitro diagnostics. Future opportunities include expanding the product line to include new reagents for emerging diagnostic tests and personalized medicine applications. The segment also focuses on ensuring regulatory compliance and maintaining high standards of quality assurance.